Electronic drugs and delivery systems are reaching the market, giving drug developers and healthcare providers a way to improve patient compliance and more. Emily Waltz reports.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Machine Learning in Clinical Trials: A Primer with Applications to Neurology
Neurotherapeutics Open Access 30 May 2023
-
Integrating ART adherence support technologies in the care of pregnant and postpartum people with HIV: a qualitative study
Implementation Science Communications Open Access 02 August 2022
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Waltz, E. Drugs go wireless. Nat Biotechnol 34, 15–18 (2016). https://doi.org/10.1038/nbt.3446
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.3446
This article is cited by
-
A swallowable X-ray dosimeter for the real-time monitoring of radiotherapy
Nature Biomedical Engineering (2023)
-
Machine Learning in Clinical Trials: A Primer with Applications to Neurology
Neurotherapeutics (2023)
-
Integrating ART adherence support technologies in the care of pregnant and postpartum people with HIV: a qualitative study
Implementation Science Communications (2022)
-
Pear approval signals FDA readiness for digital treatments
Nature Biotechnology (2018)
-
FDA snubs first smart pill
Nature Biotechnology (2016)